Transplantation, HomologousHematopoietic Stem Cell TransplantationTransplantation, AutologousBone Marrow TransplantationGraft vs Host DiseasePeripheral Blood Stem Cell TransplantationBlood Transfusion, AutologousTransplantation ConditioningHematologic NeoplasmsGraft SurvivalCombined Modality TherapyLymphocyte Culture Test, MixedTransplantation, IsogeneicTreatment OutcomeStem Cell TransplantationT-LymphocytesTransplantation ChimeraMelphalanHematopoietic Stem Cell MobilizationCyclophosphamideRecurrenceIsoantigensRemission InductionLymphoma, Non-HodgkinWhole-Body IrradiationHistocompatibilityAntineoplastic Combined Chemotherapy ProtocolsLeukemiaGranulocyte Colony-Stimulating FactorGraft vs Tumor EffectLymphocyte ActivationMultiple MyelomaCytotoxicity, ImmunologicAntigens, CD34Tissue DonorsCarmustineLeukemia, Myeloid, AcuteSurvival AnalysisEtoposideRetrospective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBusulfanSalvage TherapyLeukapheresisTime FactorsImmunosuppressionDendritic CellsT-Lymphocytes, CytotoxicHodgkin DiseaseSkin TransplantationGraft vs Leukemia EffectBlood Component RemovalAnemia, AplasticCytarabineHistocompatibility TestingSurvival RateMyeloablative AgonistsGraft vs Host ReactionLymphocytesImmunotherapy, AdoptiveNeoplasm, ResidualTransplantation ImmunologyHematopoietic Stem CellsGraft RejectionCells, CulturedLymphocyte DepletionVincristineMice, Inbred BALB CMice, Inbred C57BLHLA AntigensImmunosuppressive AgentsHematopoiesisBone Marrow PurgingSpleenCytotoxicity Tests, ImmunologicFeasibility StudiesFollow-Up StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaAntigens, NeoplasmImmunotherapySiblingsImmune ToleranceInterleukin-2Killer Cells, NaturalCD4-Positive T-LymphocytesAcute DiseaseActuarial AnalysisVidarabineLeukocyte TransfusionFlow CytometryInfectionOpportunistic InfectionsBlood TransfusionDisease-Free SurvivalImmunophenotypingCD8-Positive T-LymphocytesCancer VaccinesAntigens, CDAntibodies, MonoclonalRadiation Chimera